Regional Infectious Diseases and Infusion Center, Inc. – Trademark Portfolio
Entity Type: 03
Regional Infectious Diseases and Infusion Center, Inc. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 3 filings in this category. Currently, 1 trademark is registered. Notable registered marks include REMOVING BARRIERS TO HEALING. The owner is based in LaGrange, GA.
505 Jenkins Street
LaGrange, GA 30240
Showing of trademarks Trademarks
Trademark Classifications
Regional Infectious Diseases and Infusion Center, Inc.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Regional Infectious Diseases and Infusion Center, Inc. have?
Regional Infectious Diseases and Infusion Center, Inc. has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned, 1 cancelled.
What trademark classes does Regional Infectious Diseases and Infusion Center, Inc. file in?
Regional Infectious Diseases and Infusion Center, Inc. files trademarks across 1 Nice Classification class. The most active classes are Class 44 (Medical Services). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.
What are Regional Infectious Diseases and Infusion Center, Inc.'s most well-known trademarks?
Regional Infectious Diseases and Infusion Center, Inc.'s registered trademark portfolio includes well-known marks such as REMOVING BARRIERS TO HEALING. These are among 1 currently registered trademark in the portfolio.
What is Regional Infectious Diseases and Infusion Center, Inc.'s trademark registration success rate?
Regional Infectious Diseases and Infusion Center, Inc. has a 33% trademark registration rate, with 1 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.